Disease Overview：Endometrial polyp（EP）
Endometrial polyps are benign, localized overgrowths of endometrial glands and stroma that protrude into the uterine cavity. They commonly present with abnormal uterine bleeding—including menorrhagia, intermenstrual spotting, or postmenopausal bleeding—and may contribute to infertility or recurrent pregnancy loss due to mechanical interference with embryo implantation or altered endometrial receptivity. Diagnosis relies on transvaginal ultrasound (TVUS), saline infusion sonohysterography (SIS), or diagnostic hysteroscopy; definitive management involves hysteroscopic polypectomy—a minimally invasive, outpatient procedure with high diagnostic and therapeutic accuracy. Histopathological examination is essential to exclude atypical hyperplasia or malignancy, particularly in peri- or postmenopausal patients.
China offers distinct advantages for international patients seeking treatment: its reproductive medicine centers integrate advanced hysteroscopic platforms (e.g., high-definition electrosurgical systems and fluid management devices), adhere to stringent national clinical guidelines, and report >95% complete polyp resection rates with low recurrence (<5% at 12 months). Leading hospitals—many accredited by JCI or ISO—demonstrate robust outcomes across diverse patient profiles, including complex cases involving multiple or large polyps (>2 cm) or concurrent adenomyosis. Treatment costs in China average 40–60% lower than in the US, UK, or Germany, without compromising quality or safety standards. As a dedicated medical tourism agency, we facilitate seamless access to these services: coordinating appointments with certified reproductive endocrinologists and hysteroscopy specialists, providing itemized, transparent pricing upfront, arranging visa support, accommodation, and multilingual clinical liaison—all tailored to ensure continuity of care and informed decision-making.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Endometrial Polyps (Reproductive Medicine Department)
Non-Surgical / Conservative Management
*Indicated for asymptomatic, small (<1 cm), or postmenopausal patients with low malignancy risk; or those declining surgery.*
- •Transvaginal Ultrasound (TVUS): $45–$65 (baseline imaging)
- •Hysteroscopy-guided biopsy (office-based): $120–$180 (includes local anesthesia, pathology)
- •Progestin therapy (e.g., oral dydrogesterone 10 mg/day × 3 months): $15–$25/month × 3 = $45–$75 (drug only; excludes monitoring)
- •Follow-up TVUS + endometrial thickness measurement: $45–$65 per scan
- •Annual surveillance package (TVUS + CA-125 + clinical exam): $110–$160
Surgical / Interventional Options
*Indicated for symptomatic polyps (AUB, infertility, >1 cm), recurrent polyps, or suspicious features.*
- •Preoperative Workup (mandatory):
- •Hysteroscopic Polypectomy (outpatient, under IV sedation or local anesthesia):
- Includes hysteroscope use, resectoscope, tissue retrieval, pathology processing
- •Hysteroscopic Polypectomy + Endometrial Ablation (for recurrent polyps + heavy bleeding): $850–$1,200
- •Dilation & Curettage (D&C) alone (not recommended as primary treatment): $320–$460 — *lower efficacy, higher recurrence*
Special/Complex Condition Management
- •Polyps in IVF candidates: Hysteroscopic polypectomy + *endometrial receptivity assay (ERA)*: $1,350–$1,780 (polypectomy + ERA lab fee)
- •Postmenopausal polyps with atypical hyperplasia on biopsy: Polypectomy + *diagnostic hysteroscopy + targeted endometrial sampling*: $920–$1,300
- •Large (>2 cm) or pedunculated polyps requiring operative hysteroscopy (under general anesthesia): $1,100–$1,550 (includes anesthesia, OR time, extended monitoring)
Quick Selection Guide
- •<35 years, infertility-seeking, single <1.5 cm polyp: Hysteroscopic polypectomy ($480–$720) — highest live birth rate improvement (RR 1.62).
- •45–55 years, menorrhagia, comorbid hypertension/diabetes: Hysteroscopic polypectomy + ablation ($850–$1,200) — balances symptom control and surgical safety.
- •>60 years, asymptomatic, postmenopausal, <1 cm: Conservative surveillance ($110–$160/year) — avoids unnecessary intervention; malignancy risk <0.3%.
- •Budget-constrained (<$500), mild spotting, no fertility goals: Progestin trial + TVUS follow-up ($45–$75 + $45–$65 × 2 = $135–$205 total) — acceptable if polyp stable at 3-month scan.
- •Recurrent polyps (>2 episodes): Polypectomy + intrauterine levonorgestrel-releasing system (LNG-IUS) insertion ($480–$720 + $220 LNG-IUS device fee = $700–$940) — reduces 1-year recurrence from 25% to 6%.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
